Cyclopharm (ASX:CYC) received an additional installation purchase order from a US Department of Veterans Affairs hospital for its Technegas product after its deployment under the Federal Supply
Schedule, according to a Tuesday Australian bourse filing.
Technegas is a structured ultra-fine dispersion of radioactive labelled carbon, which allows for views and tomography imaging under a gamma or single photon emission computed tomography camera.
Its sales receipts in the US exceeded $1 million since commercial sales began last year. Its US installed base as of March 31 reached 27 technegas systems, from 17 systems as of Dec. 31, 2024.